Sponsor content
425 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Jun-2025Prescription medicine evaluationActive ingredient: gepotidacin mesilate dihydrate.
-
Jun-2025Prescription medicine evaluationActive ingredient: depemokimab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMJJARA momelotinib (as dihydrochloride monohydrate) 100 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMJJARA momelotinib (as dihydrochloride monohydrate) 200 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMJJARA momelotinib (as dihydrochloride monohydrate) 150 mg film-coated tablet bottle.
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: dostarlimab.